Amparo Luque-Sierra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amparo Luque-Sierra has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Franz Martín
Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), 41092 Seville, University of Pablo de Olavide‐University of Sevilla‐CSIC Seville Spain
3 shared publications - Enrique Martínez-Force
Instituto de la Grasa (CSIC), Universidad Pablo de Olavide, Sevilla, Spain
2 shared publications - Lourdes María Varela Pérez
Laboratory of Cellular and Molecular Nutrition, Instituto de la Grasa, Consejo Superior de Investigaciones Científicas (CSIC), Seville, Spain
2 shared publications - Abbas Ishaq
Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
1 shared publication - Alberto Sanz
University of Glasgow
1 shared publication - Alejandra Guerra-Castellano
Institute for Chemical Research, cicCartuja, University of Seville-CSIC, Seville, Spain
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Elsevier in SSRN Electronic Journal
Drought Stress Tolerance in the Wild Tomato Solanum chilense Is Associated with Altered Lipid Metabolism
Cultivated tomato (Solanum lycopersicum) and its wild relative species provide a valuable model for identifying physiological adaptations, transcriptional responses, and metabolic pathways that have evolved in nature to cope with abiotic stresses. We determined the drought tolerance in twenty-seven wild tomato accessions and three domesticated cultivars and investigated whether specific patterns of triacylglycerol (TAG) and diacylglycerol (DAG) accumulation and fatty acid remodeling in selected tolerant accessions contribute to drought adaptation. Among the thirty populations evaluated during the screening process, two S. chilense accessions exhibiting high and moderate drought tolerance were identified and selected, together with a cultivar used as a control, for further lipid analyses. Leaves from plants displaying moderate and severe drought stress symptoms showed significant differences in both TAG content and their fatty acid composition between drought and normal irrigation whereas no significant changes were detected in higher drought tolerant plants. Neither DAG content nor their fatty acid composition showed statistically significant changes in any of the three lines analyzed under drought or control conditions. In addition, although no significant modifications were found in the abundance of the analysed phospholipids, substantial changes were observed in monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG), the predominant galactolipids of chloroplast thylakoid membranes displayed distinct accumulation patterns in the drought-tolerant accession. Overall, our findings reveal specific lipid metabolic adjustments associated with drought tolerance in tolerant tomato species and provide valuable insights into the mechanisms employed by plants to withstand water-deficit conditions.
- 30 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDrought Stress Tolerance in the Wild Tomato Solanum chilense Is Associated with Altered Lipid Metabolism
Cultivated tomato (Solanum lycopersicum) and its wild relative species provide a valuable model for identifying physiological adaptations, transcriptional responses, and metabolic pathways that have evolved in nature to cope with abiotic stresses. We determined the drought tolerance in twenty-seven wild tomato accessions and three domesticated cultivars and investigated whether specific patterns of triacylglycerol (TAG) and diacylglycerol (DAG) accumulation and fatty acid remodeling in selected tolerant accessions contribute to drought adaptation. Among the thirty populations evaluated during the screening process, two S. chilense accessions exhibiting high and moderate drought tolerance were identified and selected, together with a cultivar used as a control, for further lipid analyses. Leaves from plants displaying moderate and severe drought stress symptoms showed significant differences in both TAG content and their fatty acid composition between drought and normal irrigation whereas no significant changes were detected in higher drought tolerant plants. Neither DAG content nor their fatty acid composition showed statistically significant changes in any of the three lines analyzed under drought or control conditions. In addition, although no significant modifications were found in the abundance of the analysed phospholipids, substantial changes were observed in monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG), the predominant galactolipids of chloroplast thylakoid membranes displayed distinct accumulation patterns in the drought-tolerant accession. Overall, our findings reveal specific lipid metabolic adjustments associated with drought tolerance in tolerant tomato species and provide valuable insights into the mechanisms employed by plants to withstand water-deficit conditions.
- Open Access
- 26 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (26) , eaec9499
NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice
The NLRP3 inflammasome has been implicated in a wide range of human diseases, including cardiovascular, metabolic, neurodegenerative (such as Alzheimer’s disease), and other age-related conditions. This has positioned NLRP3 as a promising pharmacological target. Numerous studies have shown that complete NLRP3 ablation can prevent or mitigate these diseases. However, total elimination of NLRP3 is not a feasible therapeutic strategy for the millions of patients affected by these degenerative disorders. Consequently, drug development efforts have focused on partial inhibition of NLRP3 using compounds that reduce its expression or activity. Paradoxically, although many studies have used Nlrp3 knockout mouse models, Nlrp3 haploinsufficient mice—more representative of the effects of pharmacological inhibition—are rarely included and remain poorly characterized. Here, we report the long-term effects of Nlrp3 haploinsufficiency during aging. Although no overt differences were observed in early life, by 16 months of age, Nlrp3 heterozygous mice exhibited signs of accelerated inflammatory aging, driven by compensatory overexpression of NLRP1. Mechanistic studies provide evidence of a previously unidentified interaction between NLRP1 and NLRP3, forming a hybrid inflammasome that drives NLRP1-mediated inflammatory overactivation when NLRP3 expression is reduced. Accordingly, anti-inflammatory treatment provided notable but moderate improvement of the inflammatory phenotype, whereas genetic inhibition of Nlrp1 more consistently reduced inflammation and extended health span. Our findings reveal a previously unidentified compensatory interaction between NLRP1 and NLRP3 and suggest that multiinflammasome inhibition may offer a more effective strategy for treating aging and age-related diseases.
- 26 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (26) , eaec9499
Open AccessNLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice
The NLRP3 inflammasome has been implicated in a wide range of human diseases, including cardiovascular, metabolic, neurodegenerative (such as Alzheimer’s disease), and other age-related conditions. This has positioned NLRP3 as a promising pharmacological target. Numerous studies have shown that complete NLRP3 ablation can prevent or mitigate these diseases. However, total elimination of NLRP3 is not a feasible therapeutic strategy for the millions of patients affected by these degenerative disorders. Consequently, drug development efforts have focused on partial inhibition of NLRP3 using compounds that reduce its expression or activity. Paradoxically, although many studies have used Nlrp3 knockout mouse models, Nlrp3 haploinsufficient mice—more representative of the effects of pharmacological inhibition—are rarely included and remain poorly characterized. Here, we report the long-term effects of Nlrp3 haploinsufficiency during aging. Although no overt differences were observed in early life, by 16 months of age, Nlrp3 heterozygous mice exhibited signs of accelerated inflammatory aging, driven by compensatory overexpression of NLRP1. Mechanistic studies provide evidence of a previously unidentified interaction between NLRP1 and NLRP3, forming a hybrid inflammasome that drives NLRP1-mediated inflammatory overactivation when NLRP3 expression is reduced. Accordingly, anti-inflammatory treatment provided notable but moderate improvement of the inflammatory phenotype, whereas genetic inhibition of Nlrp1 more consistently reduced inflammation and extended health span. Our findings reveal a previously unidentified compensatory interaction between NLRP1 and NLRP3 and suggest that multiinflammasome inhibition may offer a more effective strategy for treating aging and age-related diseases.
- Open Access
White Button Mushroom Extracts Modulate Hepatic Fibrosis Progression, Inflammation, and Oxidative Stress In Vitro and in LDLR-/- Mice
Liver fibrosis can be caused by non-alcoholic steatohepatitis (NASH), among other conditions. We performed a study to analyze the effects of a nontoxic, water-soluble extract of the edible mushroom Agaricus bisporus (AB) as a potential inhibitor of fibrosis progression in vitro using human hepatic stellate cell (LX2) cultures and in vivo in LDLR-/- mice. Treatment of LX2 cells with the AB extract reduced the levels of fibrotic and oxidative-related markers and increased the levels of GATA4 expression. In LDLR-/- mice with high-fat diet (HFD)-induced liver fibrosis and inflammation, the progression of fibrosis, oxidative stress, inflammation, and apoptosis were prevented by AB extract treatment. Moreover, in the mouse model, AB extract could exert an antiatherogenic effect. These data suggest that AB mushroom extract seems to exert protective effects by alleviating inflammation and oxidative stress during the progression of liver fibrosis, possibly due to a decrease in Toll-like receptor 4 (TLR4) expression and a reduction in Nod-like receptor protein 3 (NLRP3) inflammasome activation. In addition, we observed a potential atheroprotective effect in our mouse model.
Open AccessWhite Button Mushroom Extracts Modulate Hepatic Fibrosis Progression, Inflammation, and Oxidative Stress In Vitro and in LDLR-/- Mice
Liver fibrosis can be caused by non-alcoholic steatohepatitis (NASH), among other conditions. We performed a study to analyze the effects of a nontoxic, water-soluble extract of the edible mushroom Agaricus bisporus (AB) as a potential inhibitor of fibrosis progression in vitro using human hepatic stellate cell (LX2) cultures and in vivo in LDLR-/- mice. Treatment of LX2 cells with the AB extract reduced the levels of fibrotic and oxidative-related markers and increased the levels of GATA4 expression. In LDLR-/- mice with high-fat diet (HFD)-induced liver fibrosis and inflammation, the progression of fibrosis, oxidative stress, inflammation, and apoptosis were prevented by AB extract treatment. Moreover, in the mouse model, AB extract could exert an antiatherogenic effect. These data suggest that AB mushroom extract seems to exert protective effects by alleviating inflammation and oxidative stress during the progression of liver fibrosis, possibly due to a decrease in Toll-like receptor 4 (TLR4) expression and a reduction in Nod-like receptor protein 3 (NLRP3) inflammasome activation. In addition, we observed a potential atheroprotective effect in our mouse model.
- 12 June 2018
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 62 (13) , e1800295
Extra‐Virgin Olive Oil with Natural Phenolic Content Exerts an Anti‐Inflammatory Effect in Adipose Tissue and Attenuates the Severity of Atherosclerotic Lesions in Ldlr−/−.Leiden Mice
Scope: The present study investigates the effect of olive oils with different phenolic content in high‐fat diets (HFDs) on hypertrophy and inflammation in adipose tissue and associated atherosclerosis, in the context of obesity.Methods and results: Ldlr−/−.Leiden mice were fed three different HFDs for 32 weeks and were compared with mice fed the standard low‐fat diet (LFD). The different fats provided in the HFDs were lard (HFD‐L), extra‐virgin olive oil (EVOO; 79 mg kg–1 of phenolic compounds, HFD‐EVOO), or EVOO rich in phenolic compounds (OL, 444 mg kg–1 of phenolic compounds, HFD‐OL). All HFD‐fed mice became obese, but only HFD‐L–induced adipocyte hypertrophy. HFD‐EVOO mice exhibited the greatest levels of Adiponectin in adipose tissue and presented atherosclerotic lesions similar to the LFD group, with a very low count of monocyte/macrophage compared with HFD‐L and HFD‐OL mice. Enrichment of the phenolic content of olive oil reduced the secretion of nitrites/nitrates in the aorta, but atherosclerosis was not attenuated in HFD‐OL mice compared to other HFD mice.Conclusion: Consumption of olive oil with a natural content of phenolic compounds attenuates adipose tissue hypertrophy and inflammation and exerts antiatherosclerotic effects in mice. A higher phenolic content of olive oil did not provide further benefits in the prevention of atherosclerosis.
- 12 June 2018
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 62 (13) , e1800295
Extra‐Virgin Olive Oil with Natural Phenolic Content Exerts an Anti‐Inflammatory Effect in Adipose Tissue and Attenuates the Severity of Atherosclerotic Lesions in Ldlr−/−.Leiden Mice
Scope: The present study investigates the effect of olive oils with different phenolic content in high‐fat diets (HFDs) on hypertrophy and inflammation in adipose tissue and associated atherosclerosis, in the context of obesity.Methods and results: Ldlr−/−.Leiden mice were fed three different HFDs for 32 weeks and were compared with mice fed the standard low‐fat diet (LFD). The different fats provided in the HFDs were lard (HFD‐L), extra‐virgin olive oil (EVOO; 79 mg kg–1 of phenolic compounds, HFD‐EVOO), or EVOO rich in phenolic compounds (OL, 444 mg kg–1 of phenolic compounds, HFD‐OL). All HFD‐fed mice became obese, but only HFD‐L–induced adipocyte hypertrophy. HFD‐EVOO mice exhibited the greatest levels of Adiponectin in adipose tissue and presented atherosclerotic lesions similar to the LFD group, with a very low count of monocyte/macrophage compared with HFD‐L and HFD‐OL mice. Enrichment of the phenolic content of olive oil reduced the secretion of nitrites/nitrates in the aorta, but atherosclerosis was not attenuated in HFD‐OL mice compared to other HFD mice.Conclusion: Consumption of olive oil with a natural content of phenolic compounds attenuates adipose tissue hypertrophy and inflammation and exerts antiatherosclerotic effects in mice. A higher phenolic content of olive oil did not provide further benefits in the prevention of atherosclerosis.
- 13 December 2016
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 61 (3)
An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high‐fat “Western‐type” diet in mice
Scope: We evaluated the protective effect of extra virgin olive oil (EVOO) in high‐fat diets (HFDs) on the inflammatory response and liver damage in a nonalcoholic fatty liver disease (NAFLD) mouse model.Methods and results: C57BL/6J mice were fed a standard diet or a lard‐based HFD (HFD‐L) for 12 wk to develop NAFLD. HFD‐fed mice were then divided into four groups and fed for 24 wk with the following: HFD‐L, HFD‐EVOO, HFD based on phenolics‐rich EVOO, and reversion (standard diet). HFD‐L‐induced metabolic disorders were alleviated by replacement of lard with EVOO. EVOO diets improved plasma lipid profile and reduced body weight, plasma and epididymal fat INF‐γ, IL‐6 and leptin levels, and macrophage infiltration. Moreover, NAFLD activity scores were reduced. The liver lipid composition showed an increase in MUFAs, especially oleic acid, and a decrease in saturated fatty acids. Hepatic adiponutrin and Cd36 gene expression was upregulated in the EVOO groups. Liver ingenuity pathway analysis revealed in EVOO groups regulation of proteins involved in lipid metabolism, small molecule biochemistry, gastrointestinal disease, and liver regeneration.Conclusion: Dietary EVOO could repair HFD‐induced hepatic damage, possibly via an anti‐inflammatory effect in adipose tissue and modifications in the liver lipid composition and signaling pathways.
- 13 December 2016
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 61 (3)
An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high‐fat “Western‐type” diet in mice
Scope: We evaluated the protective effect of extra virgin olive oil (EVOO) in high‐fat diets (HFDs) on the inflammatory response and liver damage in a nonalcoholic fatty liver disease (NAFLD) mouse model.Methods and results: C57BL/6J mice were fed a standard diet or a lard‐based HFD (HFD‐L) for 12 wk to develop NAFLD. HFD‐fed mice were then divided into four groups and fed for 24 wk with the following: HFD‐L, HFD‐EVOO, HFD based on phenolics‐rich EVOO, and reversion (standard diet). HFD‐L‐induced metabolic disorders were alleviated by replacement of lard with EVOO. EVOO diets improved plasma lipid profile and reduced body weight, plasma and epididymal fat INF‐γ, IL‐6 and leptin levels, and macrophage infiltration. Moreover, NAFLD activity scores were reduced. The liver lipid composition showed an increase in MUFAs, especially oleic acid, and a decrease in saturated fatty acids. Hepatic adiponutrin and Cd36 gene expression was upregulated in the EVOO groups. Liver ingenuity pathway analysis revealed in EVOO groups regulation of proteins involved in lipid metabolism, small molecule biochemistry, gastrointestinal disease, and liver regeneration.Conclusion: Dietary EVOO could repair HFD‐induced hepatic damage, possibly via an anti‐inflammatory effect in adipose tissue and modifications in the liver lipid composition and signaling pathways.